Key facts
- This page summarizes Duane M. DeSisto's Form 4 filing for Modular Medical, Inc. (MODD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2026, 16:30.
Duane M. DeSisto - 30 Jun 2026 Form 4 Insider Report for Modular Medical, Inc. (MODD)
- Reporting relationship
- Director
- Issuer ticker
- MODD
- Reported as of
- 30 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2026, 16:30:29 UTC
- Prior SEC filing
- 08 Apr 2026
- Next SEC filing
- 01 Oct 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Sullivan, attorney-in-fact for Duane M. DeSisto
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Duane M. DeSisto filed Form 4 for Modular Medical, Inc. (MODD) on 02 Jul 2026.
Change
- Previous filing in this sequence was filed on 08 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001365746
Primary reporting owner
DeSisto Duane M
- Relationship
- Director
- Address
- C/O MODULAR MEDICAL, INC., 10740 THORNMINT ROAD, SAN DIEGO
- Signature
- /s/ James Sullivan, attorney-in-fact for Duane M. DeSisto
- Signature date
- 02 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MODD
transaction
Common stock
Award
- Transaction value
- Shares
- +83
- Change %
- +0.97%
- Price
- Shares after
- 8,627
- Date
- 30 Jun 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The Issuer issued these shares to the Reporting Person in accordance with its Outside Director Compensation Plan.
Footnote F2
Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.